Also, according to the TROPIOC-Lung02 Study, a clinical trial on combination therapy with pembrolizumab presented at World Conference on Lung Cancer (WLCLC) in August 2022, the Dato-DXd and pembrolizumab combo therapy as the primary treatment for non-small cell lung cancer (NSCLC) showed treatm...
Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with beta-blockers. Sci. Transl. Med. 2017, 9, eaao4307. [CrossRef] 11. Nielsen, L.; Curtis, T.; Kristensen, T.S.; Nielsen, N.R. What characterizes persons with high levels of perceived stress in...